Provided by Tiger Trade Technology Pte. Ltd.

MaxCyte Inc

0.7005
-0.0297-4.07%
Volume:686.88K
Turnover:485.16K
Market Cap:74.73M
PE:-1.63
High:0.7392
Open:0.7392
Low:0.6806
Close:0.7302
52wk High:4.32
52wk Low:0.6806
Shares:106.67M
Float Shares:96.17M
Volume Ratio:0.76
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4299
EPS(LYR):-0.3916
ROE:-23.19%
ROA:-13.66%
PB:0.41
PE(LYR):-1.79

Loading ...

MaxCyte Expects Core Revenue of Up to $29.6 Million for 2025

Reuters
·
Jan 13

MaxCyte sees Q4 core revenue $6.6M-$6.7M, consensus $9.3M

TIPRANKS
·
Jan 12

BRIEF-Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results

Reuters
·
Jan 12

MaxCyte Inc - Q4 Core Revenue Expected Between $6.6 Mln and $6.7 Mln

THOMSON REUTERS
·
Jan 12

Press Release: MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Jan 12

MaxCyte Announces Planned CFO Transition In 2026

Reuters
·
Nov 20, 2025

MaxCyte Q3 Revenue USD 6.4 Million Vs. IBES Estimate USD 8.37 Million

Reuters
·
Nov 20, 2025

MaxCyte reiterates FY25 revenue guidance flat to down 10% vs. last year

TIPRANKS
·
Nov 13, 2025

MaxCyte reports Q3 EPS (12c), consensus (9c)

TIPRANKS
·
Nov 13, 2025

MaxCyte Announces Q3 Results and Operational Restructuring

TIPRANKS
·
Nov 13, 2025

MaxCyte Q3 revenue falls 16% hurt by lower sales in instruments

Reuters
·
Nov 13, 2025

MaxCyte CFO Douglas Swirsky to Step Down in 2026

Reuters
·
Nov 13, 2025

MaxCyte reports third quarter 2025 revenue of $6.8 million

Reuters
·
Nov 13, 2025

MaxCyte Q3 EPS $(0.12) Misses $(0.11) Estimate, Sales $6.829M Miss $8.370M Estimate

Benzinga
·
Nov 13, 2025

BRIEF-MaxCyte Announces Planned CFO Transition In 2026

Reuters
·
Nov 13, 2025

MaxCyte Inc - Swirsky to Remain CFO Until Successor Appointed

THOMSON REUTERS
·
Nov 13, 2025

MaxCyte Announces Planned CFO Transition in 2026

GlobeNewswire
·
Nov 13, 2025

BRIEF-MaxCyte Q3 Gross Profit USD 5.2 Million

Reuters
·
Nov 13, 2025

MaxCyte Q3 Net Income USD -12.4 Million

THOMSON REUTERS
·
Nov 13, 2025

Press Release: MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance

Dow Jones
·
Nov 13, 2025